Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
RO1-HF253 | Human | FITC-Labeled Human ROR1 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
RO1-HF258 | Human | FITC-Labeled Human ROR1 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
RO1-H5256 | Human | Human ROR1 Protein, Mouse IgG2a Fc Tag | ![]() |
||
MBR-K009 | Human | ROR1-coupled magnetic beads | |||
RO1-H82E6 | Human | Biotinylated Human ROR1 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
RO1-H821y | Human | Biotinylated Human ROR1 Protein, Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
RO1-R5221 | Rat | Rat ROR1 Protein, His Tag | ![]() |
![]() ![]() |
|
RO1-H82F4 | Human | Biotinylated Human ROR1 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
RO1-H5223 | Human | Human ROR1 (308-395, Kringle domain) Protein, His Tag | ![]() |
![]() ![]() |
|
RO1-H5222 | Human | Human ROR1 (165-305, Frizzled domain) Protein, His Tag | ![]() |
![]() ![]() |
|
RO1-H5221 | Human | Human ROR1 (39-151, Ig-like domain) Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
RO1-M5250 | Mouse | Mouse ROR1 Protein, Fc Tag | ![]() |
![]() ![]() |
|
RO1-M5221 | Mouse | Mouse ROR1 Protein, His Tag | ![]() |
![]() ![]() |
|
RO1-H522y | Human | Human ROR1 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
RO1-H5250 | Human | Human ROR1 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
Loaded Anti-Human ROR1 MAb (Mouse IgG1) on AMC Biosensor, can bind Human ROR1, His Tag (Cat. No. RO1-H522y) with an affinity constant of 10.2 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
HG-030 | HG-030 | Phase 1 Clinical | Hitgen Ltd | Neoplasms | Details |
ROR1R-CAR | Phase 1 Clinical | The University Of Texas M.D. Anderson Cancer Center, Cll Global Research Foundation Alliance | Leukemia | Details | |
NBE-002 | NBE-002 | Phase 2 Clinical | Nbe-Therapeutics Ag | Triple Negative Breast Neoplasms | Details |
Cirmtuzumab | UC-961 | Phase 2 Clinical | University Of California | Ovarian Neoplasms; Lymphoma, Mantle-Cell; Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
This web search service is supported by Google Inc.